<i>Vital Signs:</i> Deaths Among Persons with Diagnosed HIV Infection, United States, 2010–2018

Bosh, Karin A.; Johnson, Anna Satcher; Hernández, Ángela; Prejean, Joseph; Taylor, Jocelyn; Wingard, Rachel; Valleroy, Linda A.; Hall, H. Irene

doi:10.15585/mmwr.mm6946a1

Cited by 48 publications

(26 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PLHIV on antiretroviral treatment have a life expectancy approaching the general population and have experienced significant decreases in HIV/AIDS‐related mortality over the previous decades 68,69 . The key health challenges faced by PLHIV now relate to chronic diseases thought to stem from a combination of factors including chronic immune activation, coinfections and drug toxicities.…”

Section: Prognosismentioning

confidence: 99%

HIV: the changing paradigm

Raubinger

Lee

Pinto

2022

Internal Medicine Journal

View full text Add to dashboard Cite

The past four decades have seen enormous progress in the diagnosis and management of human immunodeficiency virus (HIV) infection. There have been significant advances spanning the approval of the first antiretroviral agents, the advent of combination antiretroviral therapy to single tablet regimens with minimal toxicity. Although these remarkable developments have on the surface led to the 'end of AIDS', there are still key populations being left behind. This clinical update will describe the diagnosis and management of HIV, and the changing paradigms that have seen HIV transform from a life-limiting condition to a manageable chronic disease over a few decades.

show abstract

Section: Prognosismentioning

confidence: 99%

HIV: the changing paradigm

Raubinger

Lee

Pinto

2022

Internal Medicine Journal

View full text Add to dashboard Cite

show abstract

“…Extrapolating this trend, it is increasingly likely that the pool of HIV patients needing kidney transplant will continue to increase [6,7,29]. HIV related mortality is decreasing far more rapidly than non-HIV related deaths [43], thus there is expected to be a shortage of HIV D+ organs relative to demand.…”

Section: Comparative Cost Of Hiv Treatment With and Without Transplantmentioning

confidence: 99%

Economic Considerations in Using HCV and HIV Positive Donors for Kidney Transplant

Bhattacharyya¹,

Friedman²,

Thomas³

et al. 2021

obm transplant

View full text Add to dashboard Cite

End Stage Renal Disease is becoming more prevalent in the United States of America, with demand for kidney transplant exceeding the available organ supply. A novel method to increase the donor pool has been to consider transplanting organs from deceased patients who have had Hepatitis C Virus (HCV) or Human Immunodeficiency Virus (HIV) infections. Transplants with HCV infected kidneys are becoming more prevalent, due to increased organ supply due to increased mortality from injection opioid use. Similarly, deceased donor transplants using kidneys infected with HIV have become more common following the passage of the “HIV Organ Policy Equity (HOPE) Act” in 2013. These novel transplant strategies present distinct socioeconomic impacts which differ from those of prior transplant practices. Here, we have reviewed the costs and benefits of receiving a kidney transplant from deceased donors infected with HIV or HCV, compared to receiving a non-viremic kidney transplant.

show abstract

“…1 Because of the advances in HIV treatment, the rate of HIV-related deaths among people aged !13 years fell by nearly one-half between 2010 and 2017. 2 HIV has itself become a chronic disease. Proper antiretroviral therapy (ART) allows PLWH a nearly normal life expectancy; however, significant chronic comorbidities, such as chronic kidney disease (CKD), hypertension, diabetes mellitus (DM), hyperlipidemia, osteoporosis, and mental illness, can shorten their lifespan.…”

Section: Introductionmentioning

confidence: 99%